Jacob Steven Leach Dexcom Inc (DXCM) insider trading activity

Jacob Steven Leach is EVP, Chief Operating Officer of DEXCOM INC. Currently has a direct ownership of 268,644 shares of DXCM, which is worth approximately $23.2 Million. The most recent transaction as insider was on Jan 29, 2025, when has been sold 2,634 shares (Common Stock) at a price of $86.91 per share, resulting in proceeds of $228,920. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 269K

1.41% 3M change

2.34% 12M change

Total Value Held $23.2 Million

Jacob Steven Leach Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 29 2025	SELL Open market or private sale	$228,920 $86.91 p/Share	2,634 Reduced 0.97%	268,644 Common Stock
Jan 28 2025	BUY Grant, award, or other acquisition	-	7,107 Added 2.55%	271,278 Common Stock
Dec 16 2024	SELL Open market or private sale	$57,191 $76.87 p/Share	744 Reduced 0.28%	264,171 Common Stock
Sep 09 2024	SELL Open market or private sale	$51,585 $69.15 p/Share	746 Reduced 0.28%	264,915 Common Stock
Jun 10 2024	SELL Open market or private sale	$85,712 $115.05 p/Share	745 Reduced 0.28%	265,577 Common Stock
Mar 12 2024	SELL Open market or private sale	$1,967,627 $134.41 p/Share	14,639 Reduced 5.07%	273,913 Common Stock
Mar 12 2024	SELL Bona fide gift	-	7,736 Reduced 2.82%	266,177 Common Stock
Mar 08 2024	BUY Grant, award, or other acquisition	-	26,053 Added 8.28%	288,552 Common Stock
Jan 16 2024	SELL Open market or private sale	$491,800 $123.63 p/Share	3,978 Reduced 1.49%	262,499 Common Stock
Jan 12 2024	BUY Grant, award, or other acquisition	-	9,697 Added 3.51%	266,477 Common Stock
Dec 18 2023	SELL Sale (or disposition) back to the issuer	$357,264 $121.85 p/Share	2,932 Reduced 1.13%	256,780 Common Stock
Apr 20 2023	SELL Open market or private sale	$3,845,500 $125.0 p/Share	30,764 Reduced 10.59%	259,613 Common Stock
Mar 10 2023	SELL Sale (or disposition) back to the issuer	$1,794,542 $111.4 p/Share	16,109 Reduced 5.26%	290,377 Common Stock
Mar 08 2023	BUY Grant, award, or other acquisition	-	25,397 Added 7.65%	306,486 Common Stock
Mar 06 2023	SELL Open market or private sale	$2,082,749 $114.79 p/Share	18,144 Reduced 6.06%	281,089 Common Stock
Mar 09 2022	SELL Sale (or disposition) back to the issuer	$1,735,094 $406.06 p/Share	4,273 Reduced 5.41%	74,746 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	6,741 Added 7.86%	79,019 Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	2,925 Added 3.89%	72,247 Common Stock
Sep 09 2021	SELL Open market or private sale	$684,167 $541.7 p/Share	1,263 Reduced 1.79%	69,322 Common Stock
Jul 30 2021	SELL Open market or private sale	$5,761,873 $476.7 p/Share	12,087 Reduced 14.63%	70,554 Common Stock
Jun 09 2021	SELL Open market or private sale	$8,988,225 $395.0 p/Share	22,755 Reduced 21.59%	82,641 Common Stock
Mar 10 2021	SELL Open market or private sale	$1,942,711 $362.92 p/Share	5,353 Reduced 4.83%	105,396 Common Stock
Mar 08 2021	BUY Grant, award, or other acquisition	-	7,171 Added 6.08%	110,749 Common Stock

Also insider at

SNES

SenesTech, Inc. Basic Materials

Director

JSL